# FDA Inspection 972749 - Eurofins CDMO Alphora Inc. - April 29, 2016

Source: https://www.keypedia.com/records/fda_inspections/eurofins-cdmo-alphora-inc/3948f06b-18b1-443f-ad06-9f850cb9bffd
Source feed: FDA_Inspections

> FDA inspection 972749 of Eurofins CDMO Alphora Inc., April 29, 2016. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 972749
- Company Name: Eurofins CDMO Alphora Inc.
- Inspection Date: 2016-04-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1258608 - 2025-01-17](https://www.keypedia.com/records/fda_inspections/eurofins-cdmo-alphora-inc/0a16cbc4-1d92-487d-86c5-f93412aa7e66)
- FDA Inspection 1106349 - 2019-10-11
- [FDA Inspection 870592 - 2014-02-20](https://www.keypedia.com/records/fda_inspections/eurofins-cdmo-alphora-inc/a50f8b9f-75bb-4623-9f50-254a905da4c3)
- FDA Inspection 757080 - 2011-12-02

Company: https://www.keypedia.com/companies/eurofins-cdmo-alphora-inc/0a1af317-8d90-4723-be66-a19dc7fa04b7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c